5 completed, 1 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Kaposi's Sarcoma: new trials by email Literature Review of Kaposi's Sarcoma trials Research Report on Kaposi's Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT Tc 99m tilmanocept - Kaposi's Sarcoma | Phase 2 | Completed | Navidea Biopharmaceuticals | 5 | 2014-09-01 | 2016-09-27 |
| A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma 50 mg/m2 aldoxorubicin, 100 mg/m2 aldoxorubicin, 150 mg/m2 aldoxorubicin - Kaposi's Sarcoma, HIV Positive | Phase 2 | Completed | ImmunityBio, Inc. | 15 | 2014-04-03 | 2024-06-11 |
| Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) Maraviroc - Kaposi's Sarcoma | Phase 2 | Completed | University of California, San Francisco | 13 | 2011-03-09 | 2021-03-05 |
| PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma VEGF inhibitor PTC299, gene expression analysis, polymerase chain reaction - Kaposi's Sarcoma | Phase 1 / Phase 2 | Terminated | AIDS Malignancy Consortium | 17 | 2008-09-01 | 2018-06-06 |
| Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma Indinavir in association with Vinblastina +/- Bleomicina - Kaposi's Sarcoma | Phase 2 | Completed | Barbara Ensoli, MD, PhD | 25 | 2008-06-01 | 2016-08-30 |
| Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients Bevacizumab - Kaposi's Sarcoma, HIV Infections | Phase 2 | Completed | National Cancer Institute (NCI) | 19 | 2003-02-26 | 2017-09-06 |
Sarcoma, Kaposi (6) · HIV Infections (2) · Neoplasms (2) · AIDS-related Kaposi sarcoma (1) · Acquired Immunodeficiency Syndrome (1) · HIV Seropositivity (1) · Sarcoma (1)
DNA Virus Infections (6) · Herpesviridae Infections (6) · Infections (6) · Neoplasms by Histologic Type (6) · Neoplasms, Connective and Soft Tissue (6) · Neoplasms, Vascular Tissue (6) · Virus Diseases (6) · Sarcoma (5) · Neoplasms (4) · Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Lentivirus Infections (3)
Association (1) · Bevacizumab (1) · Biopsy (1) · Gene Expression Profiling (1) · Immunohistochemistry (1) · Indinavir (1) · Maraviroc (1) · Polymerase Chain Reaction (1) · emvododstat (1) · technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran (1)
AIDS Malignancy Consortium (1) · Barbara Ensoli, MD, PhD (1) · ImmunityBio, Inc. (1) · National Cancer Institute (NCI) (1) · Navidea Biopharmaceuticals (1) · University of California, San Francisco (1)
United States (5) · Italy (1)
Bonnie C Abbruzzese, MS, RD, CCRA (1) · Lucia Brambilla, MD (1) · Patrick Unemori, MD (1) · Robert Yarchoan, M.D. (1) · Susan E. Krown, MD (1) · Toby Maurer, MD (1)
U01CA121947 (1)